Abstract
Background Theacrine (1,3,7,9-tetramethyluric acid, TC) is a purine alkaloid rich in the tender leaves of an unusual Chinese tea known as Kucha. TC possessed diverse pharmacological activity including antioxidative, anti-inflammatory, analgesic and anti-depressive effects.
Aim In this work, sustained release tablets of TC were intended to be developed with insoluble matrix material to provide a kind of preparation of prolonged action.
Methods Direct tableting process and wet granulation tableting process were screened for preparing insoluble matrix tablets of TC. Single factor testes were carried out for the formulation optimization by using drug release behaviour as evaluation index. The parameter f2 was used to assess the similarity of the drug release behaviour of TC tablets prepared by different formulations. The common quality of TC tablets prepared by optimized formulation was investigated as well.
Results With ethyl cellulose (EC) as sustained matrix material, lactose as filler, aerosil as lubricant and anhydrous ethanol as moistening agent, the TC insoluble matrix tablets of sustained release were successfully prepared by wet granulation tableting method. The prepared TC tablets showed no obvious burst effect with about 40% released within 2 h, and TC was almost completely released within 12 h with an accumulative drug release percentage of 84.89%. The results of common examination showed that the TC tablets were in line with the requirements of Chinese Pharmacopoeia.
Conclusion TC tablets of good sustained release behaviour were prepared simply by wet granulation tableting process with EC as release control materials. This work provided scientific evidence for development of TC preparation of prolonged action.
Keywords
Full Text:
References
Wang Y, Yang X, Zheng X, Li J, Ye C, Song X. Theacrine, a purine alkaloid with anti-inflammatory and analgesic activities. Fitoterapia. 2010 Sep;81(6):627-31. doi: 10.1016/j.fitote.2010.03.008.
Y. Chuangxing, L. Yongcheng, Z. Haiyun, C. Fen, L. Xiaoyan. Isolation and analysis of purine alkaloids from Camellia ptilophylla Chang Acta Sci. Nat. Univ. Sunyatseni. 1997;36:30-33.
Zheng XQ, Ye CX, Kato M, Crozier A, Ashihara H. Theacrine (1,3,7,9-tetramethyluric acid) synthesis in leaves of a Chinese tea, kucha (Camellia assamica var. kucha). Phytochemistry. 2002 May;60(2):129-34. doi: 10.1016/s0031-9422(02)00086-9.
Johnson TB. THE DISCOVERY AND IDENTIFICATION OF A NEW PURINE ALKALOID IN TEA. Science. 1937 Apr 30;85(2209):431. doi: 10.1126/science.85.2209.431.
Ye CX, Hiroshi A, Zheng XQ, et al. New Discovery of Pattern of Purine Alkaloids in Wild Tea Tress. J Acta Scientiarum Naturalium Universitatis Sunyatseni. 2003; 42(1):62-65.
Ashihara H, Kato M, Crozier A. Distribution, biosynthesis and catabolism of methylxanthines in plants. Handb Exp Pharmacol. 2011;(200):11-31. doi: 10.1007/978-3-642-13443-2_2.
Cheng Y, Yan Z, Lu J, Ye C, Wang D.Isolation and preparation of theacrine by high-speed counter-current chromatography fromCamellia assamicavar.Kucha. J Acta Scientiarum Naturalium Universitatis Sunyatseni. 2010;49:65–9.
Li WX, Li YF, Zhai YJ, Chen WM, Kurihara H, He RR. Theacrine, a purine alkaloid obtained from Camellia assamica var. kucha, attenuates restraint stress-provoked liver damage in mice. J Agric Food Chem. 2013 Jul 3;61(26):6328-35. doi: 10.1021/jf400982c.
Xie G, Wu M, Huang Y, Cao Y, Li L, Zhou H, Zhu R, Liao Y, Kurihara H. Experimental study of theacrine on antidepressant effects. Chin Pharmacol Bull 2009;9:13.
Gao M, Zheng J, Zheng C, Huang Z, Huang Q. Theacrine alleviates chronic inflammation by enhancing TGF-?-mediated shifts via TGF-?/SMAD pathway in Freund's incomplete adjuvant-induced rats. Biochem Biophys Res Commun. 2020 Feb 12;522(3):743-748. doi: 10.1016/j.bbrc.2019.11.126.
Chansanroj K, Betz G. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction. Acta Biomater. 2010 Aug;6(8):3101-9. doi: 10.1016/j.actbio.2010.01.044.
Colombo P, Bettini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today. 2000 Jun;3(6):198-204. doi: 10.1016/s1461-5347(00)00269-8.
Crowley MM, Schroeder B, Fredersdorf A, Obara S, Talarico M, Kucera S, McGinity JW. Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion. Int J Pharm. 2004 Jan 28;269(2):509-22. doi: 10.1016/j.ijpharm.2003.09.037.
Nguyen TT, Hwang KM, Kim SH, Park ES. Development of novel bilayer gastroretentive tablets based on hydrophobic polymers. Int J Pharm. 2020 Jan 25;574:118865. doi: 10.1016/j.ijpharm.2019.118865.
Verhoeven J, Schutte SC, Peschier LJC, Danhof M, Junginger HE. The design of a dry-coated controlled-release tablet for oxprenolol with microporous polypropylene powder. J Control Release. 1989;10(2):205-17.
Grund J, Koerber M, Walther M, Bodmeier R. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets. Int J Pharm. 2014 Jul 20;469(1):94-101. doi: 10.1016/j.ijpharm.2014.04.033.
Moustafine RI, Bodrov AV, Kemenova VA, Rombaut P, Van den Mooter G. Drug release modification by interpolymer interaction between countercharged types of Eudragit® RL 30D and FS 30D in double-layer films. Int J Pharm. 2012 Dec 15;439(1-2):17-21. doi: 10.1016/j.ijpharm.2012.09.044.
Cuppok Y, Muschert S, Marucci M, Hjaertstam J, Siepmann F, Axelsson A, Siepmann J. Drug release mechanisms from Kollicoat SR:Eudragit NE coated pellets. Int J Pharm. 2011 May 16;409(1-2):30-7. doi: 10.1016/j.ijpharm.2011.02.026.
Polli JE, Rekhi GS, Augsburger LL, Shah VP. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci. 1997 Jun;86(6):690-700. doi: 10.1021/js960473x.
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Journal of Pharmaceutical and Biomedical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.